StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SGHT

Sight Sciences, Inc.

SGHT Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$5.53
+0.27 +5.13%

Key statistics

from XBRL data in SEC filings
Market cap
$301M
Revenue (TTM)
$79.6M
Net income (TTM)
-$37.3M
EPS (TTM)
$-0.70
P/E ratio
Dividend yield
Free cash flow
-$29.9M
Cash
$85.0M
Total assets
$110M
Gross margin
86.2%
52-week range
$3.19 – $9.24

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2026 8-K Regulation FD disclosure Apr 23, 2026 8-K Regulation FD disclosure Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 4, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 4, 2026 8-K Entered a material agreement Feb 3, 2026 8-K Results of operations (earnings release) Jan 13, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Nov 6, 2025 8-K Regulation FD disclosure; Other events Oct 17, 2025 8-K Entered a material agreement Sep 30, 2025 8-K Exit or disposal costs; Director or officer change; Regulation FD disclosure Aug 27, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 8-K Director or officer change; Shareholder vote results Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2025 8-K Director or officer change; Regulation FD disclosure Apr 22, 2025 10-K Fiscal year ended 2024-12-31 Mar 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 5, 2025 8-K Director or officer change Jan 28, 2025 8-K Results of operations (earnings release) Jan 14, 2025 8-K Took on a direct financial obligation; Unregistered sale of equity Dec 11, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Nov 7, 2024 8-K Other events Oct 3, 2024 8-K Other events Sep 26, 2024 10-Q Quarter ended 2024-06-30 Aug 2, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 1, 2024 8-K Shareholder vote results Jun 7, 2024 8-K Other events May 30, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 8-K Completed an acquisition or disposition; Regulation FD disclosure May 2, 2024 8-K Other events Apr 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 13, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 7, 2024 8-K Director or officer change Feb 2, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jan 23, 2024